Vimarsana
Biggest News Aggregation in the World

Page 42 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

Ocular Therapeutix? Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint - Vimarsana News

Ocular Therapeutix? Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint

Ocular Therapeutix, Inc. announced topline results from its Phase 2 clinical trial of OTX-CSI for the treatment of dry eye disease . The Phase 2, U.S.-based, randomized, double-masked, multi-center,... | October 23, 2021

CNN The Lead With Jake Tapper October 20, 2021 21:01:00 - Vimarsana News

CNN The Lead With Jake Tapper October 20, 2021 21:01:00

Earners. that had been central to financing this package and talking to democrats, they are trying to figure out a way to get around that opposition, either to try to convince her to change her mind or perhaps look at other ways to raise revenue. i just caught up with a chief tax writer about sinema's opsigss, and he said this. >> i think every democrat in the house and senate voted against the trump tax cuts. this is a chance to address it. so if you were against it, this is a chance to repair it. one of the most difficult issues here remains. we have still never seen a top line from the sena...

CNN The Lead With Jake Tapper October 20, 2021 21:02:00 - Vimarsana News

CNN The Lead With Jake Tapper October 20, 2021 21:02:00

Number. the house tried to propose this $3.5 trillion plan which will be significantly scaled back. but despite these divisions there's optimism among the democratic leaders if they can get a topline overall agreement, an outline on this plan by the end of this week and that could pave the way for final house passage on the separate infrastructure bill that's been waiting in the house for months. that $1.2 trillion bill to pump in money for roads, bridges, broadband. but if there's agreement on the big bill, perhaps on the narrower bill but still a ways to go. >> manu raju, thank you. my next ...

Biogen Inc.: Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS - Vimarsana News

Biogen Inc.: Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS

In the Phase 3 VALOR study, the primary endpoint as measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) did not reach statistical significance; however, signs of reduced

Biogen Inc.: Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual Meeting - Vimarsana News

Biogen Inc.: Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual Meeting

CAMBRIDGE, Mass., Oct. 14, 2021Inc. (Nasdaq: BIIB) today announced topline results from its pivotal Phase 3 VALOR study of tofersen (BIIB067), an investigational antisense oligonucleotide (ASO) drug being